Form 4: iRhythm Director Karen Ling Receives RSU Grant

Director Karen Ling acquired 1,573 restricted stock units in iRhythm Holdings, Inc. as part of an equity compensation grant.

Summary

• Director Karen Ling was granted 1,573 restricted stock units (RSUs) on May 27, 2026.
• Each RSU represents a contingent right to receive one share of iRhythm Holdings, Inc. (IRTC) common stock.
• The RSUs vest on the earlier of one year from the grant date or the date of the company's next annual meeting.
• Following this transaction, the reporting person holds 11,141 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• None identified; this is a standard equity grant for a board member.

Risks

• None identified; this is a routine disclosure of director compensation.

Future Outlook

The RSUs are subject to vesting conditions based on time or the next annual meeting, indicating standard long-term incentive alignment.

Industry Context

StockSavvy.ai notes that equity grants to board members are standard corporate governance practices in the medical technology sector to ensure long-term alignment with shareholder value.

Comparison to Industry Standards

• The grant of RSUs to non-employee directors is consistent with standard compensation practices for publicly traded companies in the healthcare technology space.
• The vesting schedule (one year or next annual meeting) is typical for board-level equity compensation.

Stakeholder Impact

• Minimal impact; reflects standard director compensation practices.

Next Steps

• Vesting of the 1,573 RSUs on the earlier of May 27, 2027, or the date of the next annual meeting.

Key Dates

Keywords

iRhythm, IRTC, Form 4, Director Compensation, Insider Transaction, Restricted Stock Units